MEDIPOST Co., Ltd. (078160.KQ)
KRW 12000.0
(-11.37%)
KRW 12000.0
(-11.37%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 65.31 Billion KRW | 17.61% |
| 2022 | 54.68 Billion KRW | 52.55% |
| 2021 | 35.84 Billion KRW | 14.7% |
| 2020 | 31.25 Billion KRW | -13.5% |
| 2019 | 36.13 Billion KRW | -0.99% |
| 2018 | 36.49 Billion KRW | -1.73% |
| 2017 | 37.13 Billion KRW | 55.4% |
| 2016 | 23.89 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 17.17 Billion KRW | -10.64% |
| 2024 Q2 | 20.15 Billion KRW | 15.82% |
| 2023 Q1 | 14.46 Billion KRW | 0.22% |
| 2023 Q2 | 14.78 Billion KRW | 2.2% |
| 2023 Q3 | 15.79 Billion KRW | 6.9% |
| 2023 Q4 | 19.21 Billion KRW | 21.63% |
| 2023 FY | 64.31 Billion KRW | 17.61% |
| 2022 Q2 | 12.88 Billion KRW | 12.19% |
| 2022 FY | 54.68 Billion KRW | 52.55% |
| 2022 Q4 | 14.42 Billion KRW | -8.82% |
| 2022 Q3 | 15.82 Billion KRW | 22.83% |
| 2022 Q1 | 11.48 Billion KRW | 11.0% |
| 2021 Q3 | 8.54 Billion KRW | 0.0% |
| 2021 FY | 35.84 Billion KRW | 14.7% |
| 2021 Q4 | 10.34 Billion KRW | 21.1% |
| 2020 FY | 31.25 Billion KRW | -13.5% |
| 2019 FY | 36.13 Billion KRW | -0.99% |
| 2018 FY | 36.49 Billion KRW | -1.73% |
| 2017 FY | 37.13 Billion KRW | 55.4% |
| 2016 FY | 23.89 Billion KRW | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| HLB Co., Ltd. | 109.98 Billion KRW | 40.616% |
| iNtRON Biotechnology, Inc. | 7.84 Billion KRW | -732.478% |
| BINEX Co., Ltd. | 55.67 Billion KRW | -17.313% |
| Bioneer Corporation | 204.55 Billion KRW | 68.07% |
| Anterogen.Co.,Ltd. | 7.74 Billion KRW | -743.84% |
| CrystalGenomics, Inc. | 32.36 Billion KRW | -101.776% |
| Helixmith Co., Ltd | 37.36 Billion KRW | -74.791% |
| Chabiotech Co.,Ltd. | 285.93 Billion KRW | 77.158% |
| Medy-Tox Inc. | 110.88 Billion KRW | 41.097% |
| Peptron, Inc. | 16.65 Billion KRW | -292.126% |
| Amicogen, Inc. | 52.82 Billion KRW | -23.647% |
| Genexine, Inc. | 41.62 Billion KRW | -56.9% |
| HLB Therapeutics Co.,Ltd. | 16.16 Billion KRW | -304.013% |
| LegoChem Biosciences, Inc. | 98.61 Billion KRW | 33.771% |
| ALTEOGEN Inc. | 40.93 Billion KRW | -59.556% |
| PharmaResearch Co., Ltd. | 89.44 Billion KRW | 26.974% |
| SillaJen, Inc. | 5.11 Billion KRW | -1177.614% |
| JETEMA, Co., Ltd. | 25.66 Billion KRW | -154.496% |
| OliX Pharmaceuticals,Inc | 35.24 Billion KRW | -85.292% |
| Genomictree Inc. | 16.26 Billion KRW | -301.569% |
| MedPacto, Inc. | 26.91 Billion KRW | -142.631% |
| D&D Pharmatech | 32.16 Billion KRW | -103.073% |
| EASY BIO,Inc. | 29.67 Billion KRW | -120.123% |
| GI Innovation, Inc. | 57.59 Billion KRW | -13.407% |